← All stocks

OKYO Pharma Ltd

OKYO No buying or selling

CIK 0001849296 #4479 in the set updated 22 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

6 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

CERRONE GABRIELE M

Director

—

10,873,916

$16.31M

+3.3%

JACOB GARY S

CHIEF DEVELOPMENT OFFICER

—

112,420

$168.63K

+3.2%

BRANCACCIO JOHN P

Director

—

35,201

$52.80K

+16.6%

Patil Rajkumar V.

Chief Scientific Officer

—

20,030

$30.05K

+20.2%

Mantelli Flavio

CHIEF MEDICAL OFFICER

—

20,000

$30.00K

—

Dempsey Robert John

CHIEF EXECUTIVE OFFICER

—

15,000

$22.50K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 18 May 2022